If you're new here, you may want to subscribe to my RSS feed. Thanks for visiting!
Women in Balance, a leading association of doctors, healthcare professionals and other advocates for women’s health, today called on the Food and Drug Administration (FDA) to preserve the choices women have for hormone therapy. The call was prompted by a recent filing with the FDA from Wyeth that questioned the safety and efficacy of bioidentical hormone replacement therapies.
Read release here
BUENOS AIRES (Reuters Health) – In all regions of the world, more than half of postmenopausal women with the crippling bone disease osteoporosis are vitamin D deficient, regardless of age, latitude or season, researchers from US, the Netherlands and UK said here last week at the 11th World Congress on the Menopause.
Read it here
The addition of testosterone to hormone therapy in women after menopause enhances their sexual function. However, it may also reduce HDL cholesterol (the “good” cholesterol) in women, according to a systematic review of current evidence.
“If the reduction in HDL had been associated with an increase in triglycerides [fatty acids] or LDL cholesterol it would be of great concern,” said Dr. Susan Davis, professor of medicine at Monash University, Melbourne, Australia, and study co-author “However, as an isolated finding the significance is difficult to interpret.” She added, “Testosterone has not been found to alter other coronary heart disease risk factors.”
Read it here
Richard White toiled in his laboratory at the Medical College of Georgia for eight years trying to understand how estrogen helped prevent heart attacks and stroke. His studies looked promising; estrogen seemed to prime the female cardiovascular system to prevent clotting and relax blood vessels.
So when the massive Women’s Health Initiative results were released three years ago — finding that estrogen therapy in older postmenopausal women seemed to cause more heart attacks and strokes — White was dumbfounded.
Read story here
Researchers from YaleUniversity’s School of Medicine have reported updated results from twoclinical studies they are conducting in women with late-stage ovarian cancerand in women with early-stage cancer of the cervix and vagina.
These data were presented on Saturday October 22, 2005 by Gil Mor, M.D.,Ph.D., associate professor of obstetrics, gynecology and reproductivesciences, Yale University School of Medicine, at the 11th World Congress onthe Menopause, International Menopause Society in Buenos Aires, Argentina, andhas been claimed as a breakthrough in management of these highly aggressivecancers by the use of the investigational anti-cancer drug, phenoxodiol (PXD).
Read release here
A mixture of two Greek words Andro and Pauses, the literal meaning of Andropause is male masculinity decline. Originally Andropause was defined as male menopause but that was highly controversial. Signs and Symptoms
Before moving any further it is necessary to learn about the signs and symptoms of Andropause. Most common within the age group of 40s and 50s and occasionally in the 30s Andropause reduces the production of testosterone. The gradual decline, most often fully realized between the ages of 50 and 55, can produce a variety of changes and effects on the male body.
Read it here
Why certain women reach menopause early and possible new warnings for sex drugs like Viagra are the topic of Thursday’s Health Alert.Millions of men take anti impotence drugs which are among the most often prescribed medications.
Now a prominent consumer group wants the most serious warnings put on those drugs.Studies show a small number of men, taking Viagra, Cialis and Levitra have suffered vision loss. The drugs already carry warning labels about that.
Read story here
TWINS are up to five times more likely to go through the menopause at an early age, leading fertility scientists have discovered.
A study of 850 female twins, both identical and non-identical, in Britain and Australia found 15 per cent of them were infertile by the age of 45 compared to 5 per cent among the general population. Under the age of 40, 5 per cent of female twins were menopausal compared to the average figure of just 1 per cent.
Read story here
IT’S HARD ENOUGH BEING a woman in corporate America. Try being one going through menopause.
You’re sitting in a meeting of mostly men when a wave of heat starts burning up inside you. Sweat drips down your face. But bring attention to the issue? Most women will go to great lengths to hide their symptoms. Some even quit their jobs.
They will tell you it’s just too dangerous a topic at work. There’s the fear of appearing weak, out of control or over the hill. Some women have taken leaves of absence because they were so embarrassed, which later affected their ability to move up in an organization.
Read story here
Older women feel ‘fobbed off’ by their doctors
Women are being fobbed off with antidepressants to help them cope with menopausal symptoms because doctors are too busy to listen to them, research has revealed.
A poll of 2,000 women in the UK found that 90 per cent were unhappy with the way they were treated by GPs when seeking treatment for symptoms of the menopause. Amazingly, one in three women who had visited their GP to discuss HRT said they had been prescribed antidepressants instead.
Read story here
Menopause Articles | admin October 31, 2005 | 
Comments (0) 
